Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact.

Abstract

A distinct gene family of widely distributed and well-modulated two-pore-domain background potassium (K(2P)) channels establish resting membrane potential and cell excitability. By using new mouse models in which K(2P)-channel genes are deleted, the contributions of these channels to important physiological functions are now being revealed. Here, we highlight results of recent studies using mice deleted for K(2P)-channel subunits that uncover physiological functions of these channels, mostly those of the TASK and TREK subgroup. Consistent with activation of these K(2P) channels by volatile anesthetics, TASK-1, TASK-3 and TREK-1 contribute to anesthetic-induced hypnosis and immobilization. The acid-sensitive TASK channels are not required for brainstem control of breathing by CO(2) or pH, despite widespread expression in respiratory-related neurons. TASK channels are necessary, however, for homeostatic regulation of adrenal aldosterone secretion. The heat-, stretch- and lipid-activated TREK-1 channels contribute to temperature and mechanical pain sensation, neuroprotection by polyunsaturated fatty acids and, unexpectedly, mood regulation. The alkaline-activated TASK-2 channel is necessary for HCO(3)(-) reabsorption and osmotic volume regulation in kidney proximal tubule cells. Development of compounds that selectively modulate K(2P) channels is crucial for verifying these results and assessing the efficacy of therapies targeting these interesting channels.

• Authors: Douglas A Bayliss, Paula Q Barrett
• Journal: Trends in pharmacological sciences (Trends Pharmacol Sci) Vol. 29 Issue 11 Pg. 566-75 (Nov 2008) ISSN: 0165-6147 [Print] England
• PMID: 18823665 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)

Chemical References

• Potassium Channel Blockers
• Potassium Channels, Tandem Pore Domain

Topics

• Animals
• Humans
• Potassium Channel Blockers (pharmacology)
• Potassium Channels, Tandem Pore Domain (agonists, antagonists & inhibitors, drug effects, genetics)